★ 4.0 (115 reviews)

JOHN NILES MD

CONDITIONS TREATED: Hypertension, Kidney Stones and Failure, Cryoglobulinemia, Focal Segmental Glomerulosclerosis, Lupus, Membranous, Granulomatosis with Polyangiitis (GPA), Churg Strauss, Lupus Nephritis, IG A Nephropathy, Hennoch Schoenlein Purpura & Membranoproliferative Glomerulonephritis in Boston

Clinic: MASSACHUSETTS GENERAL HOSPITAL

Address: 🗺️ 101 Merrimac Street, 1st Floor, Boston, MA 02114

Phone: +1-617-726-4132

Email: jlniles@partners.org

Website: Visit Website

Insurance Accepted: Aetna, Beech Street, Blue Cross Blue Shield, Blue Cross Blue Shield Medicare, Cigna, Commonwealth Care Alliance, Coventry, Fallon Health, Harvard Pilgrim Health Care, Humana, Maine Community Health Options, Mass General Brigham Health Plan, MassHealth, Medicaid CT, Medicaid ME, Medicaid NH, Medicaid NY, Medicaid RI, Medicaid VT, Medicare, Medicare ACO, Multiplan, Railroad Medicare, Senior Whole Health, TriCare, Tufts Health Plan, Unicare, United Health Care, WellSense & WellSense NH

Experience: Since 1988

Available Timing

Working hours not explicitly listed. Please call the clinic for availability.

About JOHN NILES

Meet Dr. John L. Niles, an esteemed nephrologist with over two decades of experience practicing in Boston. Dr. Niles, a graduate of the Oregon Health and Science University School of Medicine, is board-certified in Internal Medicine and Nephrology by the American Board of Internal Medicine. Known for his pioneering work in the field, Dr. Niles is credited with the discovery of the C-ANCA protein, a crucial advancement in ANCA associated vasculitis research. Since 1988, he has been a leading figure in investigating and developing assays related to ANCA, with a focus on ANCA associated vasculitis. Throughout his illustrious career, Dr. Niles has conducted extensive clinical studies to improve the understanding of ANCA tests and treatments for ANCA-related conditions. Furthermore, since 1986, he has been actively contributing to the development of continuous renal replacement therapies, including a simplified and safer approach for using citrate anticoagulation with CVVH.Key Highlights:- Over 42 years of professional experience.- Telehealth services are available for remote consultations.